The U.S. Food and Drug Administration (FDA) recently announced a recall of certain Medtronic Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds). These devices are used to treat patients with irregular heart rhythms (arrhythmia). Medtronic sen
On March 9, 2018, ABC News reported that a Katy, Texas mom was cooking with her Instant Pot when it exploded in her kitchen, causing her to suffer serious burn injuries. This is one more of many similar incidents, where pressure cookers allegedly unexpectedly exploded…
On March 1, 2018, the U.S. Consumer Product Safety Commission (CPSC) announced a recall of about 104,000 “Instant Pots,” because of a manufacturer defect that can cause the multicooker to overheat and melt on the underside, creating a fire hazard. Though the Instant Pot is…
On January 23, 2018, a North Carolina woman filed a new Kombiglyze XR (saxagliptin and metformin) lawsuit against manufacturers Bristol-Myers Squibb and AstraZeneca. She claims that after taking the diabetes medication, she suffered serious injuries that required hospitalization. She filed her case
The Occupational Health and Safety Administration (OSHA) has proposed a $300,000 fine against Marshall Ingredients LLC food factory, after an employee there suffered an amputation. OSHA also cited the company with eight serious and one willful violation, stating that the incident could have been pre
The U.S. Consumer Product Safety Commission (CPSC) announced on January 4, 2018, that HP was recalling about 50,000 lithium-ion batteries for their notebook computers and mobile workstations. The batteries reportedly can overheat and potentially cause fires and/or burns. According to the HP, the rec
On January 9, 2018, an Illinois man filed a new Onglyza lawsuit in the U.S. District Court for the Central District of Illinois. He claims that after taking the diabetes medication, he suffered serious injuries. He seeks in excess of $75,000 in damages. Plaintiff Claims…
Tasigna (nilotinib) is a drug manufactured by Novartis to treat chronic myelogenous leukemia (CML). The FDA approved it for this use in 2007, but since then, there have been several studies that have linked the medication with an increased risk for atherosclerosis. In 2013, Health…
On January 28, 2018, the FDA alerted consumers and their healthcare providers to the fact that Primus Pharmaceuticals had implemented a recall of all Limbrel products due to rare but potentially serious health risks. Primus is notifying distributors and is arranging for the return of…
On February 2, 2018, the U.S. Judicial Panel on Multidistrict Litigation (“JPML” or “panel”) ordered that all federally-filed Onglyza (saxagliptin) lawsuits be centralized in the Eastern District of Kentucky. That means a total of 84 cases pending in over 26 districts will be transferred to…
The Centers for Disease Control and Prevention (CDC) states that traumatic brain injuries (TBIs) are a major cause of death and disability in the U.S. They contribute to about 30 percent of injury-related deaths in the United States and they appear to be on the…
On January 2, 2018, a Mississippi man filed a Bard hernia mesh lawsuit in the Southern District of Mississippi. The plaintiff claims that after he was implanted with a Bard Ventralex mesh, he suffered from serious injuries. Plaintiff Claims that Bard Ventralex Mesh Caused Complications…